Health and Fitness Health and Fitness
Mon, July 30, 2012
[ Mon, Jul 30th 2012 ] - Market Wire
Horizon Pharma to Host Conference Call and Webcas .. Quarter 2012 Financial Results on August 10, 2012
[ Mon, Jul 30th 2012 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Announces Positive .. hase IIIb Dupuytren's Contracture Multicord Study
[ Mon, Jul 30th 2012 ] - Market Wire
ProMetic Life Sciences and NantPharma, a NantWork .. d Commercialize Plasma-Derived Biopharmaceuticals
[ Mon, Jul 30th 2012 ] - Market Wire
OncoSec Receives ISO 13485 Quality Management System Certification
[ Mon, Jul 30th 2012 ] - Market Wire
Comprehensive Care Corporation Retained by CHRIST .. to Provide Behavioral Health Management Services
[ Mon, Jul 30th 2012 ] - Market Wire
Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ (lorcaserin HCl) New Drug Application
Sun, July 29, 2012
[ Sun, Jul 29th 2012 ] - Market Wire
Basilea submits European Marketing Authorization .. on of ceftobiprole for the treatment of pneumonia
[ Sun, Jul 29th 2012 ] - Market Wire
Clinical Research on Accuray's CyberKnife and Tom .. nted at Key Industry Event for Medical Physicists
Fri, July 27, 2012
[ Fri, Jul 27th 2012 ] - Market Wire
Thousands of Uninsured Americans Receive Free Hea .. Remote Area Medical (RAM) Expedition in Wise, Va.
[ Fri, Jul 27th 2012 ] - Market Wire
Harvard and MIT Students Rally Boston to Join Glo .. nness World Record Attempt on World Hepatitis Day
[ Fri, Jul 27th 2012 ] - Market Wire
AMRI Renews Shareholder Rights Plan
[ Fri, Jul 27th 2012 ] - Market Wire
Acura Pharmaceuticals Announces Update on AVERSION Products
[ Fri, Jul 27th 2012 ] - Market Wire
Ellen M. Zane Joins Haemonetics Board of Directors
[ Fri, Jul 27th 2012 ] - Market Wire
CML HealthCare Inc. Announces Release Date for Second Quarter 2012 Financial Results
[ Fri, Jul 27th 2012 ] - Market Wire
Bacterin International Holdings, Inc. Schedules S .. d Quarter 2012 Financial Earnings Conference Call
[ Fri, Jul 27th 2012 ] - Market Wire
Insulet Corporation to Report Second Quarter 2012 Financial Results on August 8, 2012
[ Fri, Jul 27th 2012 ] - Market Wire
Sarepta Therapeutics Regains NASDAQ Compliance
[ Fri, Jul 27th 2012 ] - Market Wire
Equity Research on WellPoint Inc. and CIGNA Corp. - Tough Times for Insurers
[ Fri, Jul 27th 2012 ] - Market Wire
Micro Imaging Technology Introduces the MIT 1000 to Food Safety Industry Professionals
[ Fri, Jul 27th 2012 ] - Market Wire
Hansen Medical Announces Second Quarter 2012 Results Conference Call
[ Fri, Jul 27th 2012 ] - Market Wire
Santa Fe Petroleum, Inc. Announces the Appointmen .. om Griffin as President and Chairman of the Board
[ Fri, Jul 27th 2012 ] - Market Wire
Mylan Launches Generic Version of Sporanox Capsules
[ Fri, Jul 27th 2012 ] - Market Wire
Aethlon Medical Announces the Appointment of Thom .. nham and Philip A. Ward to its Board of Directors
Thu, July 26, 2012
[ Thu, Jul 26th 2012 ] - Market Wire
In a challenging environment, SCOR meets its targ .. income of EUR 206 million in the first half 2012
[ Thu, Jul 26th 2012 ] - Market Wire
AspenBio Pharma Engages Tiberend Strategic Adviso .. as Investor and Public Relations Agency of Record
[ Thu, Jul 26th 2012 ] - Market Wire
Insulet Appoints W. Mark Lortz to Board of Directors
[ Thu, Jul 26th 2012 ] - Market Wire
Once-Daily Dolutegravir is Non-Inferior to Twice- .. Raltegravir in Treatment-Naive Adults with HIV-1
[ Thu, Jul 26th 2012 ] - Market Wire
DURECT Corporation Invites You to Join its Second Quarter 2012 Earnings Conference Call
[ Thu, Jul 26th 2012 ] - Market Wire
NuPathe Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
[ Thu, Jul 26th 2012 ] - Market Wire
Cambrex To Announce Second Quarter 2012 Financial Results On August 1, 2012

Cambrex To Announce Second Quarter 2012 Financial Results On August 1, 2012


Published on 2012-07-26 11:47:12 - Market Wire
  Print publication without navigation


Cambrex To Announce Second Quarter 2012 Financial Results On August... -- EAST RUTHERFORD, N.J. , July 26, 2012 /PRNewswire/ --

Cambrex To Announce Second Quarter 2012 Financial Results On August 1, 2012

[ ]

EAST RUTHERFORD, N.J., July 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: [ CBM ]) announced that second quarter 2012 financial results will be released on Wednesday, August 1, 2012 after the market closes.

The Company will host a conference call to discuss the second quarter 2012 financial results. 

 


Second Quarter 2012 Earnings Conference Call



When:                

Thursday, August 2, 2012 at 8:30 a.m. Eastern Time



Dial-in:                 

1-888-312-9841 for U.S.


1-719-325-2423 for International


Passcode:  4333709



Dial-in Replay:        

1-888-203-1112 for U.S.


1-719-457-0820 for International


Passcode:  4333709


Available through Thursday, August 9, 2012



Webcast:              

[ www.cambrex.com ]

                                  

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit [ www.cambrex.com ].   

 

SOURCE Cambrex Corporation



[ Back to top ]

RELATED LINKS
[ http://www.cambrex.com ]

Contributing Sources